These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18971847)

  • 1. [Massive hemorrhage following photodynamic therapy in exudative ARMD].
    Hartmann L; Adenis JP; Robert PY
    J Fr Ophtalmol; 2008 Sep; 31(7):714.e1-7. PubMed ID: 18971847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large submacular hemorrhage following PDT with verteporfin in patients with occult CNVM secondary to age-related macular degeneration.
    Chaudhry NA; Lavaque AJ; Tom DE; Liggett PE
    Ophthalmic Surg Lasers Imaging; 2007; 38(1):64-8. PubMed ID: 17278540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triamcinolone and PDT to treat exudative age-related macular degeneration and submacular hemorrhage.
    Ruiz-Moreno JM; Montero JA; Barile S
    Eur J Ophthalmol; 2006; 16(3):426-34. PubMed ID: 16761245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulatory changes in the choroidal vasculature after verteporfin-based photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
    Isola V; Pece A; Brancato R
    Retina; 2004 Aug; 24(4):618-20. PubMed ID: 15300088
    [No Abstract]   [Full Text] [Related]  

  • 5. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
    Verteporfin In Photodynamic Therapy Study Group
    Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization.
    Gelisken F; Inhoffen W; Partsch M; Schneider U; Kreissig I
    Am J Ophthalmol; 2001 Apr; 131(4):518-20. PubMed ID: 11292425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy for choroidal neovascularization associated with submacular hemorrhage in age-related macular degeneration.
    Bakri SJ; Nickel J; Yoganathan P; Beer PM
    Ophthalmic Surg Lasers Imaging; 2006; 37(4):278-83. PubMed ID: 16898387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.
    Azab M; Benchaboune M; Blinder KJ; Bressler NM; Bressler SB; Gragoudas ES; Fish GE; Hao Y; Haynes L; Lim JI; Menchini U; Miller JW; Mones J; Potter MJ; Reaves A; Rosenfeld PJ; Strong A; Su XY; Slakter JS; Schmidt-Erfurth U; Sorenson JA; ;
    Retina; 2004 Feb; 24(1):1-12. PubMed ID: 15076937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exudative complications after photodynamic therapy.
    Holz ER; Linares L; Mieler WF; Weinberg DV
    Arch Ophthalmol; 2003 Nov; 121(11):1649-52. PubMed ID: 14609931
    [No Abstract]   [Full Text] [Related]  

  • 10. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
    Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
    Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
    Bressler NM; Arnold J; Benchaboune M; Blumenkranz MS; Fish GE; Gragoudas ES; Lewis H; Schmidt-Erfurth U; Slakter JS; Bressler SB; Manos K; Hao Y; Hayes L; Koester J; Reaves A; Strong HA;
    Arch Ophthalmol; 2002 Nov; 120(11):1443-54. PubMed ID: 12427056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large submacular hemorrhages after verteporfin therapy.
    Do DV; Bressler NM; Bressler SB
    Am J Ophthalmol; 2004 Mar; 137(3):558-60. PubMed ID: 15013883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Submacular hemorrhage following photodynamic therapy in the treatment of choroidal neovascularization].
    Díaz-de-Durana-Santa-Coloma E; Fernández-Ares ML; Iturralde-Errea D; Salazar-Díez JL; Vázquez-Cruchaga E; López-Garrido JA
    Arch Soc Esp Oftalmol; 2006 Dec; 81(12):685-91. PubMed ID: 17199162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy.
    Ladd BS; Solomon SD; Bressler NM; Bressler SB
    Am J Ophthalmol; 2001 Nov; 132(5):659-67. PubMed ID: 11704027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choroidal infarction following photodynamic therapy with verteporfin.
    Klais CM; Ober MD; Freund KB; Ginsburg LH; Luckie A; Mauget-Faÿsse M; Coscas G; Gross NE; Yannuzzi LA
    Arch Ophthalmol; 2005 Aug; 123(8):1149-53. PubMed ID: 16087856
    [No Abstract]   [Full Text] [Related]  

  • 17. Retinal hemorrhage after photodynamic therapy in patients with subfoveal choroidal neovascularization caused by age-related macular degeneration.
    Theodossiadis GP; Panagiotidis D; Georgalas IG; Moschos M; Theodossiadis PG
    Graefes Arch Clin Exp Ophthalmol; 2003 Jan; 241(1):13-8. PubMed ID: 12545287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
    Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
    Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verteporfin therapy in age-related macular degeneration (VAM): an open-label multicenter photodynamic therapy study of 4,435 patients.
    Bessler NM;
    Retina; 2004 Aug; 24(4):512-20. PubMed ID: 15300071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.